Other studies have demonstrated that persistently elevated serum IL-6 levels during COVID-19 are independently associated with in-hospital mortality, and rises of serum IL-6, IL-8 and TNF-α are probably age-dependent, translating to poorer outcomes among the elderly [22,24,33]. This evidence concerns the gene IL6 and COVID-19.